Current Depression Trials in Melbourne
If you or your loved one would like to learn more about any of the following clinical research depression trials in Melbourne, please email us and one of our trial coordinators will contact you.
You can also book an appointment with a trial coordinator right on this page – just click on Schedule an Interview button.
BEDROC: A Phase 2A Proof-of-Concept Study of R-107 for the Treatment of Refractory Major Depressive Disorder
Doctors Are Researching Potential New Investigational Drugs
Doctors are looking for people with major depressive disorder (MDD) to volunteer for a clinical trial in Melbourne of an investigational study medication for depression.
People with major depressive disorder who volunteer and qualify may have the opportunity to try this study medication and receive at no cost:
- Study-related care from a local doctor
- Study medication for MDD
- Compensation for travel
PRAXIS: A Phase 2 Clinical Trial of PRAX-114 to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy in Participants with Major Depressive Disorder
The PRAX-114-202 Part B trial in Melbourne is evaluating a potential new drug designed to work alone or with an antidepressant, to see if it can help improve symptoms of depression in women with perimenopause.
PRAX-114 is a potential new investigational treatment for major depressive disorder.
In this open-label clinical trial, research participants will receive 14 daily oral doses of PRAX-114 up to 120 mg once every night.
Depending on your current antidepressant treatment experience and medical history, study participation is expected to take 6 weeks with a total of up to 7 visits.